Location: Home
  • search
  • go
  • Relate News
  • 6/22/2018Tot Biopharm Opens New Biologics Facility in Suzhou
  • 6/21/2018China's Removal of Imported Drug Tariffs: Implications for Foreign and...
  • 6/20/2018Wuxi Biologics Initiated Construction of Integrated ADC Solution Cente...
  • 6/20/2018IQVia: Overview of Urban Chinese Hospital Drug Sales in 2017
  • 6/20/2018IQVia: Overview of Chinese Urban Retail Pharmacy Market in 2017
  • 6/20/2018Overview of Chinese In-licensing of Foreign Investigational New Drugs ...
  • 6/20/2018MSF Challenges Gilead's Chinese Patent HCV Drug Velpatasvir
  • 6/20/2018European Chamber Warns China over Uneven Market Access and Treatment f...
  • 6/20/2018Sedor and Los Altos Enter Greater China License Agreement for CE-Melox...
  • 6/20/2018Luye Pharma's Class 1.1 New Analgesic to Start Phase I Trial in China
  • 6/19/2018Merck and Alibaba Health Announce Collaboration to Develop Patient-Cen...
  • 6/19/2018Johnson & Johnson Launches J&J Institute for Asia Pacific Regi...
  • 6/19/2018Alpha Biopharma Announces Series A Financing
  • 6/19/2018MNCs Lose Top Talents to Booming Domestic Biopharma Startups
  • 6/19/2018CITIC Capital Proposes To Acquire China Biologic for $3.65B
  • 6/19/2018India Releases Study for Enhancing Access to the Chinese Pharma Market
  • 6/15/2018China Adds Jinan and Changsha Airports as Drug Import Destination Port...
  • 6/15/2018Recent Official and Executive Moves
  • 6/15/2018Tsumura and PingAn Forms Chinese JV for Herbal Medicine
  • 6/15/2018BMS Wins Chinese Approval of Opdivo as First PD-1/L1 Checkpoint in Chi...
  • 6/15/2018Aptose Licenses China Rights of Crystal Genomics's AML Drug CG-806
  • 6/15/2018China's Investors Pour Into Western Biotech Startups
  • 6/15/2018China's Vaccine Tourists Drain Hong Kong's Supply of Cancer Drug
  • 6/14/2018U.S. Supreme Court Rules against Chinese Companies in Vitamin Price-fi...
  • 6/14/2018Sirtex Dumps Deal with Varian for Higher $1.4B Offer from CDH/China Gr...
  • 6/13/2018Wuxi AppTech Leads Strategic Investment into AI Firm Insilico Medicine
  • 6/13/2018CStone Initiates Two Pivotal Phase II Studies of Anti-PD-L1 mAb CS1001
  • 6/13/2018BMJ: Protecting the Accuracy of Clinical Trial Data in China
  • 6/13/2018China to Conduct Training Programs for Indian Pharma Cos
  • 6/12/2018Chinese Government Launch Support Program for Biopharma CRO and CMO Se...
  • Page:161/357 Total number of articles:10707: [First][<<] [159] [160] [161] [162] [163] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group